Walleye Capital LLC Gemini Therapeutics, Inc. Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$1.22 - $1.73 $18,575 - $26,340	-15,226 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.29 - $3.08 $13,871 - $33,119	-10,753 Reduced 41.39%	15,226 $21,000
Q4 2021 Mar 03, 2022	BUY	$2.39 - $4.0 $18,713 - $31,320	7,830 Added 43.14%	25,979 $75,000
Q3 2021 Nov 15, 2021	BUY	$3.3 - $6.32 $59,891 - $114,701	18,149 New	18,149 $73,000

2.44M

Ticker GMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,244,500
Market Cap $1.05B
Description
Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD). Its lead candidate is GEM103, a recombinant form of the human complement factor H protein to treat dry AMD patients. The company also develops GEM307 ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.